Cellular Biomedicine Stock Price

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cellular Biomedicine Group Inc CBMG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 18.00 07:00:52
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
17.90 18.69 0.79 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 18.00 USD

Cellular Biomedicine Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 350.60M 19.48M 9.01M $ 339.92k $ - -2.61 -6.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.08k -

more financials information »

Cellular Biomedicine News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBMG Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.7718.4217.7518.1132,1890.231.29%
1 Month18.2318.5017.7518.1728,716-0.23-1.26%
3 Months18.0218.7916.97518.0342,600-0.02-0.11%
6 Months14.0219.9912.9518.2384,8643.9828.39%
1 Year17.3819.9911.4816.6579,9940.623.57%
3 Years19.1025.0010.9817.3161,190-1.10-5.76%
5 Years13.9725.005.0516.0850,3514.0328.85%

Cellular Biomedicine Description

Cellular Biomedicine Group Inc is a biotechnology company focused on the development of proprietary cell therapies for the treatment of cancer and degenerative diseases. The company has two major cell platforms: immune cell therapy for treating a broad range of cancers using cancer vaccines, Chimeric Antigen Receptor T-cell technologies, and anti-PD-1 technologies; and human-adipose-derived mesenchymal progenitor cells for treatment of joint and autoimmune diseases. The immuno-oncology and stem cell research team is based in both China and the United States.

Your Recent History
Cellular B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.